| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/24/2008 | CA2658976A1 Aminoindazolylurea derivatives |
| 01/24/2008 | CA2658770A1 Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same |
| 01/24/2008 | CA2658633A1 Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 01/24/2008 | CA2657930A1 Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 01/24/2008 | CA2655238A1 Milk ingredient enriched in polar lipids and uses thereof |
| 01/23/2008 | EP1880743A1 Microneedle for delivering a substance into the dermis |
| 01/23/2008 | EP1880732A1 Parathyroid hormone formulation |
| 01/23/2008 | EP1880730A1 Functions and uses of gpr39 gene in mammalian central nervous system |
| 01/23/2008 | EP1879905A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 01/23/2008 | EP1879887A2 Npy antagonists, preparation and use |
| 01/23/2008 | EP1879881A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 01/23/2008 | EP1879862A2 Magnesium salts of hmg-coa reductase inhibitors |
| 01/23/2008 | EP1879860A2 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 01/23/2008 | EP1879605A2 Novel nutraceutical compositions |
| 01/23/2008 | EP1879600A2 Nanotubes as mitochondrial uncouplers |
| 01/23/2008 | EP1879591A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders |
| 01/23/2008 | EP1879582A2 Combination of dipeptidyl peptidase-iv inhibitor and a cannabinoid cb1 receptor antagonist for the treatment of diabetes and obesity |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1633354B1 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 01/23/2008 | EP1601352B1 Combined use of a fibrate and orlistat for the treatment of obesity |
| 01/23/2008 | EP1532144B1 quinuclidine derivatives and their use |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | EP1370159B1 Method for producing vitamin b-enriched preparations from grasses |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1175444B1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/23/2008 | CN101111523A Process for producing natural immunobiotic extract and uses thereof |
| 01/23/2008 | CN101111508A Spiroketal derivative and use thereof as diabetic medicine |
| 01/23/2008 | CN101111492A 吲哚衍生物 Indole derivatives |
| 01/23/2008 | CN101111480A 取代的吡啶酮衍生物 Substituted pyridone derivative |
| 01/23/2008 | CN101111266A Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 01/23/2008 | CN101111243A Classes of compounds that interact with integrins |
| 01/23/2008 | CN101111242A Tablets containing ornithine hydrochloride |
| 01/23/2008 | CN101111239A Composition for body fat reduction |
| 01/23/2008 | CN101111226A Medical product for inhalation containing glucagon-like peptide-1 (glp-1) |
| 01/23/2008 | CN101108878A Glp-1 analogues |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN101108252A Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same |
| 01/23/2008 | CN101108227A Konjak extractive powder capsule |
| 01/23/2008 | CN101108225A Diabetes treating capsule dose and technique of preparing the same |
| 01/23/2008 | CN101108207A Antidiabetic pharmaceutical composition and method of preparing the same |
| 01/23/2008 | CN101108197A Total polyoses from inula flower and use in regulating or treating diabetes and complication and immunoregulation |
| 01/23/2008 | CN101108196A Method of producing glossy ganoderma polypeptide product |
| 01/23/2008 | CN101108194A Method of eliminating sodium chloride in iron-dextran complex compound water solution and device thereof |
| 01/23/2008 | CN101108175A Acid-alkaline buffering composition |
| 01/23/2008 | CN101108000A Addition-application method of functional properties fat planting food mixture |
| 01/23/2008 | CN101107992A Braized three mushrooms |
| 01/23/2008 | CN100363365C Immunomodulating heterocyclic compounds |
| 01/23/2008 | CN100363364C Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 01/23/2008 | CN100363362C Thiazole derivatives as NPY receptor antagonists |
| 01/23/2008 | CN100363332C Aromatic amino acid derivative and its prepn process and medicinal use |
| 01/23/2008 | CN100363024C Chinese traditional medicine named numb pain resolvent for treating diabetes peripheral nervous lesion |
| 01/23/2008 | CN100363017C Fat-reducing compound preparation |
| 01/23/2008 | CN100363013C Mineral absorption promoter |
| 01/23/2008 | CN100363000C Chinese and western medicines composition contg. Avandia and its prepn. method |
| 01/23/2008 | CN100362998C Medicine composition for treating diabetes |
| 01/23/2008 | CN100362992C Nutritional composition for oral use |
| 01/23/2008 | CN100362988C Chinese and western medicine composition contg. metformin |
| 01/23/2008 | CN100362987C Particulate product comprising pantethine |
| 01/23/2008 | CN100362985C Chinese medicine capsules for treating coronary heart disease and hyperlipidemia and production thereof |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320972 Hypercholesterolemia, cholesterol-associated benign and malignant tumors; hyperlipidemia, arteriosclerosis, and sitosterolemia; 6) (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(2',3',4'-trimethoxybiphenyl-4-yl)azetidin-2-one |
| 01/22/2008 | US7320968 Pharmaceutical composition |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320803 Free from water of crystallization; use in foods, animal feeds, or in food supplements |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | US7320786 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 01/22/2008 | CA2495967C New synthesis process and new crystalline form for agomelatine, and pharmaceutical compositions containing it |
| 01/22/2008 | CA2490638C Combination therapy wherein a serotonin reuptake inhibitor is used |
| 01/22/2008 | CA2432884C Nutritional composition with health promoting action containing oligosaccharides |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2382535C Mixed micellar pharmaceutical delivery system and method of preparation |
| 01/22/2008 | CA2305807C Substituted fused heterocyclic compounds |
| 01/17/2008 | WO2008008895A1 Gpr119 agonists for the treatment of diabetes and related disorders |
| 01/17/2008 | WO2008008637A2 Antioxidant combinations for use in ruminant feed rations having a fat source |
| 01/17/2008 | WO2008008544A2 Equine whole food supplements |
| 01/17/2008 | WO2008008507A2 Methods of treatment of diabetes |
| 01/17/2008 | WO2008008442A1 Preparation and utility of hmg-coa reductase inhibitors |
| 01/17/2008 | WO2008008033A1 The use of naphtoquinones in the treatment and control of diabetes, insulin resistance and hyperglycemia |
| 01/17/2008 | WO2008007933A1 Epidermal growth factor increasing insulin secretion and lowering blood glucose |
| 01/17/2008 | WO2008007728A1 Oral preparation in the form enclosed in lipid membrane structure, and fatigue-ameliorating agent comprising coenzyme a as active ingredient |
| 01/17/2008 | WO2008007664A1 Bicyclic heterocyclic compound and use thereof |
| 01/17/2008 | WO2008007661A1 Tricyclic heterocyclic compound and use thereof |
| 01/17/2008 | WO2008007103A1 Furo [3, 2-b] pyrrol derivatives |
| 01/17/2008 | WO2008006922A1 Compounds for the treatment of diseases related to insulin resistance |
| 01/17/2008 | WO2008006703A1 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 01/17/2008 | WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | WO2008006547A2 Pyrrolopyrimidines for pharmaceutical compositions |
| 01/17/2008 | WO2008006432A1 Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
| 01/17/2008 | WO2008006319A1 BIBENZIMIDAZOLE DERIVATIVES HAVING PPARγ AGONIST ACTIVITY AND THEIR USES |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2008006224A1 Medicagenic acid saponin and uses thereof |
| 01/17/2008 | WO2007137098A3 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 01/17/2008 | WO2007131778A8 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith |
| 01/17/2008 | WO2007125405A3 Substituted 2-amino-fused heterocyclic compounds |